Baudax Bio Announces FDA Approval of ANJESO™ for the Management of Moderate to Severe Pain Feb 20, 2020 4:05pm EST
Baudax Bio™ Launches as a New Pharmaceutical Company Aimed at Advancing Promising, Non-Opioid Analgesic Therapies Nov 21, 2019 7:00am EST
